ID
41691
Descrizione
The primary objective of this study was to demonstrate bioequivalence between eltrombopag oral film-coated tablets manufactured at Research and Development (R&D) and Commercial sites. The subject participants each went through two dosing periods (Period 1 and Period 2), during each of which they received a single dose of eltrombopag. The dosing periods were separated by a washout of at least 10 days. For each period, subjects had to perform a visit on the day before and one on the day of the administration of the drug. Furthermore, the protocol-defined visits included a screening visit and a follow-up visit. Study ID: 105122 Clinical Study ID: 105122 Study Title: Phase I Bioequivalence Study for SB 497115 GR Phase II and Phase III Tablets Sponsor: GlaxoSmithKline Phase: phase 1 Study Recruitment Status: Completed Generic Name: Eltrombopag Study Indication: Thrombocytopenia This form has to be filled out at the Screening, the P1 D-1, P1 D1, P2 D-1, P2 D1, the Follow-Up Visits and in case of repeat measurements.
Keywords
versioni (2)
- 17/12/20 17/12/20 -
- 18/12/20 18/12/20 - Sarah Riepenhausen
Titolare del copyright
GlaxoSmithKline
Caricato su
18 dicembre 2020
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
GSK Eltrombopag Thrombocytopenia, Clinical Study ID: 105122
Electronically transferred lab data
- StudyEvent: ODM
Descrizione
Safety Labs
Alias
- UMLS CUI-1
- C0681902
Descrizione
for most of the visits defined in the study description, all of the tests are necessary. for possible repeating visits, only the repeated tests have to be filled out.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0200345
- UMLS CUI [1,3]
- C0332307
Descrizione
if clinical chemistry is taken at the same time as hematology, please choose the option "same as previous sample". The option "same as previous sample" cannot be chosen for possible repeating visits. Please specify the date of the sampling.
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0200345
- UMLS CUI [2,1]
- C0040223
- UMLS CUI [2,2]
- C0200345
Descrizione
date and time sample collection
Tipo di dati
datetime
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C0200345
- UMLS CUI [2,1]
- C0040223
- UMLS CUI [2,2]
- C0200345
Descrizione
lab test type code
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C0022885
- UMLS CUI [1,2]
- C0805701
Similar models
Electronically transferred lab data
- StudyEvent: ODM
C0200345 (UMLS CUI [1,2])
C0332307 (UMLS CUI [1,3])
C0200345 (UMLS CUI [1,2])
C0040223 (UMLS CUI [2,1])
C0200345 (UMLS CUI [2,2])
C0200345 (UMLS CUI [1,2])
C0040223 (UMLS CUI [2,1])
C0200345 (UMLS CUI [2,2])
C0805701 (UMLS CUI [1,2])